These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9577945)

  • 1. Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia.
    Kaufmann PA; Frielingsdorf J; Mandinov L; Seiler C; Hug R; Hess OM
    Circulation; 1998 Apr; 97(14):1348-54. PubMed ID: 9577945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension.
    Frielingsdorf J; Seiler C; Kaufmann P; Vassalli G; Suter T; Hess OM
    Circulation; 1996 Apr; 93(7):1380-7. PubMed ID: 8641027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries.
    Seiler C; Hess OM; Buechi M; Suter TM; Krayenbuehl HP
    Circulation; 1993 Nov; 88(5 Pt 1):2139-48. PubMed ID: 8222108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine.
    Kaufmann P; Vassalli G; Utzinger U; Hess OM
    J Am Coll Cardiol; 1995 Sep; 26(3):624-31. PubMed ID: 7642851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate.
    Seiler C; Suter TM; Hess OM
    J Am Coll Cardiol; 1995 Dec; 26(7):1615-22. PubMed ID: 7594094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of coronary vasomotion after percutaneous transluminal coronary angioplasty?
    Suter TM; Buechi M; Hess OM; Haemmerli-Saner C; Gaglione A; Krayenbuehl HP
    Circulation; 1992 Jan; 85(1):86-92. PubMed ID: 1728488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous propranolol on coronary vasomotion at rest and during dynamic exercise in patients with coronary artery disease.
    Bortone AS; Hess OM; Gaglione A; Suter T; Nonogi H; Grimm J; Krayenbuehl HP
    Circulation; 1990 Apr; 81(4):1225-35. PubMed ID: 2317905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of intracoronary and intravenous administration of propranolol on coronary vasomotility at rest and during exercise].
    Bortone A; Hess OM; Gaglione A; Locuratolo N; Troito G; Rizzon P; Chiddo A
    Cardiologia; 1989 Aug; 34(8):679-88. PubMed ID: 2605578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem alone and combined with nitroglycerin: effect on normal and diseased human coronary arteries.
    Hess OM; Nonogi H; Bortone A; Gage JE; Grimm J; Krayenbuehl HP
    Eur Heart J; 1989 Nov; 10 Suppl F():142-6. PubMed ID: 2515968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal coronary vasomotion in hypertension: role of coronary artery disease.
    Frielingsdorf J; Kaufmann P; Seiler C; Vassalli G; Suter T; Hess OM
    J Am Coll Cardiol; 1996 Oct; 28(4):935-41. PubMed ID: 8837571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of cholesterol increases coronary vasomotor tone during exercise.
    Kaufmann P; Matter C; Mandinov L; Frielingsdorf J; Seiler C; Hess OM
    Coron Artery Dis; 2000 Sep; 11(6):459-66. PubMed ID: 10966131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced coronary artery vasodilation is not impaired by stent placement.
    Maier W; Windecker S; Küng A; Lütolf R; Eberli FR; Meier B; Hess OM
    Circulation; 2002 May; 105(20):2373-7. PubMed ID: 12021223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary vasomotor activity; its significance for the therapy of angina pectoris].
    Hess OM; Nonogi H; Grimm J; Krayenbühl HP
    Schweiz Med Wochenschr; 1988 Apr; 118(14):502-7. PubMed ID: 3131874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormal coronary vasomotility in subjects with normal coronary arteries and reduced reserve of coronary flow].
    Bortone A; Hess OM; Gaglione A; Locuratolo N; Musci S; Sebastiani M; Rizzon P; Chiddo A
    Cardiologia; 1989 Jan; 34(1):33-46. PubMed ID: 2720712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia, abnormal coronary vasomotion, and calcium antagonists.
    David DS
    Circulation; 1999 Apr; 99(14):1922. PubMed ID: 10199893
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of intracoronary and intravenous propranolol on human coronary arteries.
    Hess OM; Bortone A; Gaglione A; Nonogi H; Grimm J; Krayenbuehl HP
    Eur Heart J; 1989 Nov; 10 Suppl F():153-8. PubMed ID: 2620682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary stenosis vasomotion during dynamic exercise before and after PTCA.
    Suter TM; Hess OM; Bortone A; Nonogi H; Grimm J; Krayenbuehl HP
    Eur Heart J; 1989 Dec; 10 Suppl G():58-63. PubMed ID: 2627951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of coronary vasoconstriction by diltiazem during dynamic exercise in patients with coronary artery disease.
    Nonogi H; Hess OM; Ritter M; Bortone A; Corin WJ; Grimm J; Krayenbuehl HP
    J Am Coll Cardiol; 1988 Oct; 12(4):892-9. PubMed ID: 3417988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The poststenotic vessel segment during dynamic exercise: effect of oral isosorbide-dinitrate.
    Gaglione A; Hess OM; Haemmerli C; Suter T; Kirkeeide RL; Osenberg HP; Muser M; Anliker M; Gould KL; Krayenbuehl HP
    Basic Res Cardiol; 1990; 85 Suppl 1():347-57. PubMed ID: 2091610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal coronary vasomotion during exercise in patients with normal coronary arteries and reduced coronary flow reserve.
    Bortone AS; Hess OM; Eberli FR; Nonogi H; Marolf AP; Grimm J; Krayenbuehl HP
    Circulation; 1989 Mar; 79(3):516-27. PubMed ID: 2492909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.